Table 1 Baseline characteristics of patients in the ITT safety population

Age (year), mean (SD)*

56 (10)

57 (9)

Male/female (%)*

56/44

52/48

Body weight (kg), mean (SD)

92.6 (16.6)

90.9 (15.1)

BMI (kg/m²), mean (SD)

32.5 (4.2)

32.2 (4.0)

Waist circumference (cm), mean (SD)

108.3 (11.8)

107.6 (11.5)

Systolic blood pressure (mmHg), mean (SD)

132.9 (15.7)

133.6 (15.4)

Diastolic blood pressure (mmHg), mean (SD)

80.5 (9.4)

79.8 (10.1)

Heart rate (beats per minute), mean (SD)

74.0 (9.3)

74.0 (10.1)

A1C (%), mean (SD)*

7.5 (0.7)

7.4 (0.7)

A1C (mmol/mol), mean (SD)*

58 (7.7)

57 (7.7)

Total cholesterol (mmol/L), mean (SD)

4.7 (1.0)

4.7 (1.0)

LDL-cholesterol (mmol/L), mean (SD)

2.5 (0.8)

2.5 (0.8)

HDL-cholesterol (mmol/L), mean (SD)

1.3 (0.3)

1.3 (0.3)

Triglycerides (mmol/L), mean (SD)

1.9 (1.2)

2.0 (1.3)

High sensitivity C-reactive protein (mg/L), mean (SD)

4.8 (7.7)

4.2 (5.1)

Taking antihypertensive drugs (%)

65.4

70.3

Taking lipid-lowering drugs (%)

45.6

53.4